Nevertheless, insulin appears to impact tumor growth in certain contexts, which is driven by the PI3K (Phosphoinositide 3-kinase) and mTOR (mammalian target of rapamycin) signaling pathway [10]. The gene discussed is MTOR; the disease is neoplasm.